Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Porter

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Blood|January 27, 2012
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortJanet L Kwiatkowski, Hae-Young Kim, Alexis A Thompson, et al.
Blood Advances|August 28, 2025
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND studyAli T Taher, Vip Viprakasit, Antonis Kattamis, et al.
British Journal of Haematology|April 25, 2015
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaClaudia R Morris, Hae-Young Kim, Elizabeth S Klings, et al.
British Journal of Haematology|September 12, 2014
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patientsJohn B Porter, Patrick B Walter, Lynne D Neumayr, et al.
American Journal of Hematology|January 3, 2023
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiencyHanny Al-Samkari, Rachael F Grace, Andreas Glenthøj, et al.
European Journal of Haematology|April 24, 2023
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspaterceptMaria Domenica Cappellini, Ali T Taher, Antonio Piga, et al.
Analytical Biochemistry|May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoformEsther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
Haematologica|April 16, 2013
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionClaudia R Morris, Hae-Young Kim, John Wood, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|August 28, 2014
Calibration of myocardial T2 and T1 against iron concentrationJohn-Paul Carpenter, Taigang He, Paul Kirk, et al.
Circulation|March 30, 2011
On T2* magnetic resonance and cardiac ironJohn-Paul Carpenter, Taigang He, Paul Kirk, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Blood|January 27, 2012
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortJanet L Kwiatkowski, Hae-Young Kim, Alexis A Thompson, et al.
Blood Advances|August 28, 2025
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND studyAli T Taher, Vip Viprakasit, Antonis Kattamis, et al.
British Journal of Haematology|April 25, 2015
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaClaudia R Morris, Hae-Young Kim, Elizabeth S Klings, et al.
British Journal of Haematology|September 12, 2014
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patientsJohn B Porter, Patrick B Walter, Lynne D Neumayr, et al.
American Journal of Hematology|January 3, 2023
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiencyHanny Al-Samkari, Rachael F Grace, Andreas Glenthøj, et al.
European Journal of Haematology|April 24, 2023
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspaterceptMaria Domenica Cappellini, Ali T Taher, Antonio Piga, et al.
Analytical Biochemistry|May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoformEsther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
Haematologica|April 16, 2013
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionClaudia R Morris, Hae-Young Kim, John Wood, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|August 28, 2014
Calibration of myocardial T2 and T1 against iron concentrationJohn-Paul Carpenter, Taigang He, Paul Kirk, et al.
Circulation|March 30, 2011
On T2* magnetic resonance and cardiac ironJohn-Paul Carpenter, Taigang He, Paul Kirk, et al.
Pageof 13